Andreas Lingnau

1.0k total citations
23 papers, 803 citations indexed

About

Andreas Lingnau is a scholar working on Molecular Biology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Andreas Lingnau has authored 23 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Andreas Lingnau's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Listeria monocytogenes in Food Safety (5 papers) and Microbial Inactivation Methods (5 papers). Andreas Lingnau is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Listeria monocytogenes in Food Safety (5 papers) and Microbial Inactivation Methods (5 papers). Andreas Lingnau collaborates with scholars based in Germany, Netherlands and United States. Andreas Lingnau's co-authors include Eugen Domann, Trinad Chakraborty, J Wehland, Thomas Nichterlein, Martina Hudel, Michael Bock, Walter Maier, H. M. Seitz, Gabriele Margos and Michael H.G. Kubbutat and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Andreas Lingnau

23 papers receiving 779 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andreas Lingnau Germany 15 304 244 219 138 124 23 803
Theodoros Goulas Spain 18 121 0.4× 456 1.9× 72 0.3× 177 1.3× 79 0.6× 34 901
Gunnar Pohl Sweden 14 183 0.6× 498 2.0× 45 0.2× 96 0.7× 56 0.5× 29 990
Karel H. M. van Wely Spain 21 59 0.2× 864 3.5× 70 0.3× 64 0.5× 39 0.3× 38 1.2k
H. Becker Germany 15 94 0.3× 333 1.4× 95 0.4× 206 1.5× 27 0.2× 28 767
Lucie S. Heath United States 14 50 0.2× 619 2.5× 70 0.3× 211 1.5× 81 0.7× 26 891
W L Cosand United States 17 52 0.2× 441 1.8× 44 0.2× 188 1.4× 325 2.6× 19 960
Jonathan Sjögren Sweden 14 42 0.1× 478 2.0× 32 0.1× 67 0.5× 178 1.4× 17 676
Kathrin Westphal Germany 12 480 1.6× 334 1.4× 56 0.3× 275 2.0× 433 3.5× 13 1.2k
Tibisay Guevara Spain 16 60 0.2× 383 1.6× 21 0.1× 168 1.2× 64 0.5× 31 827
Latha Pathangey United States 16 59 0.2× 483 2.0× 58 0.3× 323 2.3× 444 3.6× 26 1.1k

Countries citing papers authored by Andreas Lingnau

Since Specialization
Citations

This map shows the geographic impact of Andreas Lingnau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Lingnau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Lingnau more than expected).

Fields of papers citing papers by Andreas Lingnau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Lingnau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Lingnau. The network helps show where Andreas Lingnau may publish in the future.

Co-authorship network of co-authors of Andreas Lingnau

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Lingnau. A scholar is included among the top collaborators of Andreas Lingnau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Lingnau. Andreas Lingnau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boshuizen, Julia, Nora Pencheva, Oscar Krijgsman, et al.. (2021). Cooperative Targeting of Immunotherapy-Resistant Melanoma and Lung Cancer by an AXL-Targeting Antibody–Drug Conjugate and Immune Checkpoint Blockade. Cancer Research. 81(7). 1775–1787. 48 indexed citations
2.
Overdijk, Marije B., Kristin Strumane, Frank J. Beurskens, et al.. (2020). Dual Epitope Targeting and Enhanced Hexamerization by DR5 Antibodies as a Novel Approach to Induce Potent Antitumor Activity Through DR5 Agonism. Molecular Cancer Therapeutics. 19(10). 2126–2138. 36 indexed citations
3.
Koopman, Louise A., Mikkel G. Terp, Gijs G. Zom, et al.. (2019). Enapotamab vedotin, an AXL-specific antibody-drug conjugate, shows preclinical antitumor activity in non-small cell lung cancer. JCI Insight. 4(21). 46 indexed citations
4.
Civit, Laia, Holger Weber, Andreas Lingnau, et al.. (2019). Targeting hormone refractory prostate cancer by in vivo selected DNA libraries in an orthotopic xenograft mouse model. Scientific Reports. 9(1). 4976–4976. 15 indexed citations
5.
Overdijk, Marije B., Kristin Strumane, Antonio Ortiz Buijsse, et al.. (2019). Abstract 2391: DR5 agonist activity of HexaBody®-DR5/DR5 (GEN1029) is potentiated by C1q and independent of Fc-gamma receptor binding in preclinical tumor models. Cancer Research. 79(13_Supplement). 2391–2391. 8 indexed citations
6.
7.
Overdijk, Marije B., Michael Cecchini, Kristin Strumane, et al.. (2019). Abstract C025: HexaBody-DR5/DR5 (GEN1029) shows potent preclinical antitumor activity in a variety of patient-derived xenograft (PDX) tumor models. Molecular Cancer Therapeutics. 18(12_Supplement). C025–C025. 2 indexed citations
8.
Koopman, Louise A., Maarten L. Janmaat, Kirstine Jacobsen, et al.. (2018). Abstract 832: An AXL-specific antibody-drug conjugate shows preclinical anti-tumor activity in non-small cell lung cancer, including EGFR-inhibitor resistant NSCLC. Cancer Research. 78(13_Supplement). 832–832. 9 indexed citations
9.
Breij, Esther C.W., Sandra Verploegen, Andreas Lingnau, et al.. (2015). Preclinical efficacy studies using HuMax-Axl-ADC, a novel antibody-drug conjugate targeting Axl-expressing solid cancers.. Journal of Clinical Oncology. 33(15_suppl). 3066–3066. 6 indexed citations
10.
Krauss, Ramona, Florence F. Wagner, Bianca Dietrich, et al.. (2011). 1251 POSTER Preclinical and Clinical Development of 4SC-203 – a Novel Multi-target Kinase Inhibitor. European Journal of Cancer. 47. S160–S160. 2 indexed citations
11.
Piersma, Sander R., Ulrike Fiedler, Simone W. Span, et al.. (2010). Workflow Comparison for Label-Free, Quantitative Secretome Proteomics for Cancer Biomarker Discovery: Method Evaluation, Differential Analysis, and Verification in Serum. Journal of Proteome Research. 9(4). 1913–1922. 114 indexed citations
12.
Thomas, Maria, Frank Weise, R. Brundiers, et al.. (2008). A novel reverse transduction adenoviral array for the functional analysis of shRNA libraries. BMC Genomics. 9(1). 441–441. 7 indexed citations
13.
Miller, Kenneth E., Ulrich K. Steiner, Andreas Lingnau, et al.. (2007). Randomised prospective study of intermittent versus continuous androgen suppression in advanced prostate cancer. Journal of Clinical Oncology. 25(18_suppl). 5015–5015. 57 indexed citations
14.
Hain, Torsten, et al.. (2006). Invasiveness is a variable and heterogeneous phenotype in Listeria monocytogenes serotype strains. International Journal of Medical Microbiology. 296(4-5). 277–286. 21 indexed citations
15.
Müller, Simone, Torsten Hain, Andreas Lingnau, et al.. (1998). Purification of the inlB Gene Product of Listeria monocytogenes and Demonstration of Its Biological Activity. Infection and Immunity. 66(7). 3128–3133. 22 indexed citations
16.
17.
Lingnau, Andreas, Gabriele Margos, Walter Maier, & H. M. Seitz. (1994). Serum-free cultivation of severalPlasmodium falciparum strains. Parasitology Research. 80(1). 84–86. 8 indexed citations
18.
Lingnau, Andreas, Ekkehard Doehring-Schwerdtfeger, & Walter Maier. (1994). Evidence for 6-day cultivation of humanPlasmodium malariae. Parasitology Research. 80(3). 265–266. 10 indexed citations
19.
Lingnau, Andreas, Gabriele Margos, Walter Maier, & H. M. Seitz. (1993). Serum-free cultivation ofPlasmodium falciparum gametocytes in vitro. Parasitology Research. 79(5). 378–384. 15 indexed citations
20.
Lingnau, Andreas, Gabriele Margos, Walter Maier, & H. M. Seitz. (1993). The effects of hormones on the gametocytogenesis of Plasmodium falciparum in vitro.. PubMed. 34(3). 153–60. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Theodoros Goulas Breakdown of academic impact, for papers by Gunnar Pohl Breakdown of academic impact, for papers by Karel H. M. van Wely Breakdown of academic impact, for papers by H. Becker Breakdown of academic impact, for papers by Lucie S. Heath Breakdown of academic impact, for papers by W L Cosand Breakdown of academic impact, for papers by Jonathan Sjögren Breakdown of academic impact, for papers by Kathrin Westphal Breakdown of academic impact, for papers by Tibisay Guevara Breakdown of academic impact, for papers by Latha Pathangey
Rankless by CCL
2026